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Two hundred and ﬁfty ﬁve biological samples were collected from 188 animals (81 sheep and 107 goats) during the lambing season
from September 2009 to April 2010 from the Mafraq region of Jordan. Sampled animals belonged to 93 sheep and goat ﬂocks
that had abortion cases in the region. One hundred and seven (41.9%) biological samples were positive for the omp2 primers that
were able to identify all Brucella species in the collected samples which were obtained from 86 aborted animals (86/188 = 45.7%).
Using the B. melitensis insertion sequence 711 (IS711) primers on the 107 omp2 positive samples, only 61 conﬁrmed to be positive
for B. melitensis. These positive samples were obtained from 28 sheep and 33 goats. The prevalence rate of B. melitensis was
27.1% (51/188) among aborted animals. For diﬀerentiation between vaccine strain and ﬁeld strain infection, polymerase chain
reaction-restriction fragment length polymorphism (PCR-RFLP) method using PstI endonuclease enzyme was used. Vaccination
with Rev-1 in the last year (OR = 2.92, CI: 1.1–7.7) and grazing at common pasture (OR = 2.78, CI: 1.05–7.36) were statistically
signiﬁcant (P ≤ .05) risk factors positively associated with the occurrence of brucellosis in sheep and goat ﬂocks.
1.Introduction
Brucellosis, especially caused by B. melitensis, remains one
of the most common zoonotic diseases worldwide with
more than 500,000 human cases reported annually [1].
B. melitensis has 3 biovars (1–3), highly pathogenic for
humans [2]. Brucellosis is present throughout the ﬁve
continentsanditisstillanuncontrolledseriouspublichealth
problem in many developing countries [3]. It is endemic
in sheep and goats in most countries of the Mediterranean
basin, the Middle East, Central Asia [4, 5], with only North
America, North Europe, South-East Asia, and Oceania being
spared [6]. Animal brucellosis poses a barrier to trade of
animals and animal products between countries and causes
considerable economic losses due to abortion and fertility
problems to the sheep and goat industry [3, 7].
Control measures are based on strict hygiene and
vaccination programs. Vaccination is regarded as a measure
for reducing the prevalence of the disease to a level where
eradication by test and slaughter can be implemented. Of
the vaccines used for immunizing small ruminants against
B. melitensis, Rev-1 vaccine is generally preferred [8, 9]. The
Rev-1 vaccine is indicated to protect small ruminants against
brucellosis and to protect females from abortion in regions
where the disease occurs. Conjunctival vaccination is safer
than subcutaneous vaccination but is not safe enough to
be applied regardless of pregnancy status of animals [10]
and the duration of immunity conferred by this method of
vaccination is the subject of controversy.
Serological test, identiﬁcation of the agent by culture
and Polymerase chain reaction (PCR) test are the most
common techniques that are used for brucellosis diagnosis
[11]. Because of the hazardousness of vaccine strains that
can cause disease in human and animals, PCR-RFLP assay
is being used successfully to diﬀerentiate all vaccine strains
from ﬁeld infection using omp2 gene of brucellae which has
2a l l e l e somp2a and omp2b. This method can diﬀerentiate
ﬁeld infection with Rev-1 vaccines by producing diﬀerent
band pattern using Pst1 endonuclease enzyme [12]. Omp2a
does not have the restriction site of PstI and therefore is not2 Veterinary Medicine International
a good target for diﬀerentiation of vaccine strains with ﬁeld
strainin PCRRFLPbut omp2bhasthementioned site forthe
PstI enzyme and can be used successfully for diﬀerentiation
of all Brucella vaccine strains with the ﬁeld strains infection
[12].
B. melitensis strain Rev-1 has the normal properties of a
biovar 1 strain of B. melitensis, but develops smaller colonies
on agar media; it does not grow in the presence of basic
fuchsine, thionin (20μg/mL), or benzyl penicillin (3μg/mL)
(ﬁnal concentrations) but does grow in the presence of
streptomycin at 2.5 or 5μg/mL (5IU/mL) [13]. Vaccine
strain Rev-1 may also be identiﬁed using speciﬁc PCRs
[14].
Recently, a robust and rapid multiplex PCR assay has
been introduced which allows for the diﬀerentiation of all
nine currently recognized Brucella species including the
recently described Brucella species, B. microti, B. inopinata,
B. ceti,a n dB. pinnipedialis [15].
The purposes of this study were: (1) to identify B.
melitensis in aborted cases (sheep and goats), (2) to estimate
the prevalence rate of B. melitensis in aborted animals (sheep
and goats), (3) to identify and diﬀerentiate vaccine strain
from ﬁeld strains infection, and (4) to evaluate some risk
factors thought to be associated with the occurrence of B.
melitensis in sheep and goat ﬂocks in Mafraq region of
Jordan.
2.MaterialsandMethods
2.1. Study Area, Environment, and Management of the Flocks.
Mafraq Governorate, which lies northeast of Jordan, is
considered as the most important area for raising animals,
specially sheep and goats which are the most abundant
domestic animal in this region of Jordan. There were
about 3000 ﬂocks that were present in this region in 2009,
about 40% of the Jordanian sheep population (Ministry of
agriculture records). The main breed of sheep in Jordan is
Awassi. Sheep industry is considered an important source
of income for people in Mafraq. Sheep ﬂock of this study
could be classiﬁed as seminomadic because they move out
from their original areas for grazing in the Western parts
of Jordan during early March until the end of August.
During the rest of the year until the following spring
season, these ﬂocks were housed and group fed about
1kg straw, 600g barely, and 200g wheat-bran per head
per day.
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In the Northern part of Jordan, estrus activity of sheep
startsinmid-Julyoftheyearandlambingandkiddingseason
in Jordan extends from December to March [16]. Under
normal conditions, less than 10% of the sheep lamb twice
a year. Usually lambs are weaned at the age of 60–90 days
and most ewes are milked twice a day for an average milking
period of 120 days and an average milk production of 0.63
liter per day [17].
2.2. Study Design, Target Population, and Sample Collection.
This study was designed as a convenient cross-sectional
study, where the ﬂock was the study unit and the outcome
variable was the brucellosis status of the ﬂock, classiﬁed as
positive or negative. One positive animal in the ﬂock was
enough for the ﬂock to be classiﬁed as positive. The target
population consisted of all goat and sheep ﬂocks that were
present in Mafraq area of Jordan. There were 3000 goat and
sheep ﬂocks distributed throughout the region [18]. The
procedure and formula of Martin et al. [19] were used to
calculate the number of ﬂocks needed for this study. All
calculations were based on previously published results con-
ducted in the region by Al-Talafhah et al. [20]wh i c hr ev e a l e d
a 61% Brucella seropositive prevalence between ﬂocks and
14% within ﬂock. Also, we assumed that Brucella positive
seroprevalence ﬂocks were at higher risk for developing
abortions.
We calculated the sample size (number of ﬂocks) to be
sampled from the target population for a ﬁnite population
with an expected prevalence of 61% and speciﬁed precision
of 10% of the true prevalence with 95% certainty. The total
number of ﬂocks required for this study was 93 ﬂocks. Since
the main objective of this study was to study the provenance
of brucellosis among aborted animals, only goat and sheep
ﬂocks with reported abortion cases were included in this
study. We decided to select the 93 ﬂocks from the ﬂocks of
which their owners asked for veterinary services or consulted
with the Veterinary Services/Ministry of Agriculture in
Mafraq governorate to investigate the problem of abortions
in their ﬂocks during the lambing season 2009/2010. During
a successive lambing season from September 2009 to April
2010, we were able to collect biological samples from only
188 reported animals in these ﬂocks (55 goats and 133
sheep) that had abortions (many sporadic abortion cases in
these ﬂocks were not examined because farmers notiﬁed the
veterinaryserviceswhentheyhadepidemicswithseveralcase
of abortions).
It was possible to collect only 106 fetuses and 149 blood
samples from aborted animals within a week after abortion.
Of the 188 aborted animals, 67 animals had paired samples
(fetal tissue and blood of their dams obtained from 31 goats
and 36 sheep) and 121 aborted animals that had just one
sample, either blood (82 animals; 67 goats and 15 sheep) or
fetal tissues (39 animals; 9 goats and 30 sheep).
Whole blood (10mL in a tube with anticoagulant) was
collected from the jugular vein. Diﬀerent fetal tissues such
as kidney, liver, lung, and brain were collected from freshly
aborted fetuses during 24 hrs after abortion. All blood and
tissue samples were transferred to the Jordan University
of Science and Technology (JUST) laboratory using special
container with ice and were kept at −20
◦C until used for
DNA extraction and PCR analysis.Veterinary Medicine International 3
2.3. Isolation of DNA from Blood and Fetal Tissue Samples.
DNA isolation was performed according to the manufac-
turer’s instruction (DNA Puriﬁcation Kit, Promega, USA).
Brieﬂy, 300μL of blood sample was used in a 1.5mL of
a sterile eppendorf tube with 900μL of erythrocyte lysis
solution, and incubated at room temperaturefor10 minutes,
then centrifuged at 16000rpm using refrigerated eppendurf
centrifuge for 1min. The supernatant was discarded and
the leukocyte pellet was resuspended using vortexes for 20
seconds at high speed. On the resuspended white pellet,
300μL nucleic lysis solution was added and pippetted 3–5
times to lyse the white blood cells (WBCs) and then was
incubated at 37
◦C for one hour and 1.5μL of RNase solution
was added on the mixture and incubated at 37
◦C for 15–20
minutes. Then 100μL of protein precipitation solution was
added and vortexed for 20 seconds at high speed. Small
clump of protein was visible after this step. The lysate was
centrifugedat16000rpmfor4minutesatroomtemperature.
A dark brown protein pellet was visible after centrifugation.
The supernatant containing total DNA was transferred to a
fresh clean 1.5mL eppendurf tube containing 300μLr o o m
temperature Isopropanol. The solution was gently mixed
5–8 times by inversion until the white thread-like strands
of DNA formed a visible mass. DNA was recovered by
centrifuging the samples at 16000 rpm for 5 min, and the
pellet was rinsed with 300μL of 70% ethanol, dried and
then resuspended in 60μL of DNA rehydration solution.
Extracted DNA was kept at −20
◦C until used in PCR
analysis. The concentration and purity of the DNA was
determined spectrophotometrically. Also the quality and
quantity of DNA was examined by running 5μLD N A
sample after mixing with loading dye on agarose gel. Sheep
Glyceraldehyde 3-phosphate dehydrogenase (sGAPDH) was
also ampliﬁed by PCR for all extracted DNA samples to
conﬁrm the quality of DNA in our extracted DNA samples.
DNAfromfetaltissueswasextractedasfollow:brieﬂy,1g
pooled sample of diﬀerent fetal tissues with 3mL of 1X PBS
(phosphate buﬀer saline) was added in a clean 10mL white
cap tube, and then homogenized using a tissue homogenizer.
Afterhomogenization,thelysatewascentrifugedat3000rpm
for 5 minutes at 4◦C. Two hundred μl of supernatant was
transferred to a clean eppendurf tube containing 600μL
nucleic lysis solution and was pipetted many times to lyse
the cells until no clumps of cell was visible. The lysate was
incubated at 65
◦C for 15–30 minutes in the water bath. On
the cooled lysate, 3μL of RNase was added and incubated
at 37
◦C for 15–30 minutes. DNA was then obtained as
mentioned before.
2.4. Primers. Published Brucella-speciﬁc primer pairs were
used to amplify Brucella omp2 gene. These are sequences
of the forward 5 TGGAGGTCAGAAATGAAC3  and reverse
5 GAGTGCG AAACGAGCGC3  primer pairs. This primer
set could identify all species of Brucella. A single band with
the expected size of 282-bp was obtained with all isolates
[12].
The following primer pairs: AAATCGCGTCCTTGCTG-
GTCTGA and TGCCGATCACTTAAGGGCCTTCAT, spe-
ciﬁc to IS711 element of B. melitensis were used to conﬁrm
B. melitensis from aborted fetal tissues and blood samples.
The ampliﬁed product of this primer set was 731-bp [21].
2.5. Polymerase Chain Reaction (PCR). PCR ampliﬁcation
was performed using Promega Gotaq Green Master Mix
(USA) as follow: brieﬂy, the PCR was performed with
total volume of 25μL containing 12.5μLo fG o t a qG r e e n
Master Mix, 2 μL of every forward and reverse primers,
2μLM g C l 2, 4.5μLn u c l e a s ef r e ew a t e r ,a n d2μLo fg e n o m i c
DNA. Following hot start treatment at 94
◦C for 4min., PCR
was performed as follow: 35 cycles of PCR with 1 cycle
consisting of 1 min at 94
◦C for DNA denaturation, 1min
at 50
◦C for primers annealing ((for omp2 primers set) but
56
◦Cf o rB. melitensis speciﬁc primer set) and 1.5min at
72
◦C for polymerase-mediated primer extension. The last
cycle included incubation of the sample at 72
◦Cf o r1 0m i n
and was kept at 4◦C for unlimited time. Seven microliters
of the ampliﬁed product was analyzed by electrophoresis in
ethidium bromide stained 1.5% agarose gel in TBE buﬀer.
The ampliﬁed product was visualized under UV light and
thenwasphotographedusingAlphalmager(AlphaInnotech)
image documentation system.
2.6. Digestion of the Ampliﬁed Products. PCR-RFLP is used
to diﬀerentiate all vaccine strains from ﬁeld infection using
outer membrane proteins2 gene (omp2)o fb r u c e l l a ew h i c h
has 2 alleles; omp2a and omp2b. This method is able to
diﬀerentiate ﬁeld infection with Rev-1 vaccine by producing
diﬀerent band patterns using PstI endonuclease enzyme
[12]. PstI restriction enzyme was used according to the
manufacturer’s instruction (Bio labs) [12]. Brieﬂy, the 282-
bp band of PCR product of omp2g e n ew a sc u tf r o mt h e
agarosegelbyscalpel.PCR-DNAwaspuriﬁedusingPromega
Wizard SV Gel and PCR Clean up System (USA) as follow.
The band of DNA with the gel was poured in 1.5mL
eppendurf tube and then for every one mg of gel with
DNA band, an equal volume of 10μL membrane binding
solution was added and was incubated at 60
◦C for 10–20
minutes for gel to be dissolved. The dissolved gel then was
poured on a speciﬁc column membrane and was incubated
at room temperature (RT) for 2 minutes then centrifuged
at 15000rpm for one minute. The column membrane was
then rinsed twice by washing solution as follow. At ﬁrst,
700μL of washing solution was added on the central part of
membrane and was incubated at RT for 2min and then was
centrifuged for one min at 15000rpm. At the second time,
500μL of washing solution was again added on the central
part of membrane and was incubated at RT for one min and
then was centrifuged for 5 min as before. For elution of DNA
fromthecolumnmembrane,15μLofnucleasefreewaterwas
added on the central part of membrane and then centrifuged
for 1min as before.
The 282-bp DNA product of omp2 gene that was
extracted from the gel was then digested using PstIe n d o n u -
clease enzyme with total volume of 20μL as follow: twoμL
of buﬀer with 0.2μL of bovine serum albumin (BSA), 2μL
of PstIe n z y m e ,a n d4μL of puriﬁed PCR from the gel, then
completedtoaﬁnalvolumeof20μLwithnucleasefreewater.
The mixture was mixed and incubated for 16 hours at 37
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2.7. Sequencing of 16S Ribosomal RNA (rRNA) and omp2
Product. For better analysis of the origin and antigenic
characteristic of Brucella species that are present in Jordan,
extracted B. melitensis DNA and the 282-bp PCR products
(omp2) were sent for sequencing, 16S rRNA and omp2 gene
were sequenced in Macrogen Inc., Korea. A phylogenetic tree
was built using Lasergene software (Figure 3).
2.8. Data Collection. A semistructured questionnaire (writ-
ten in Arabic language and available upon request from
the author) was developed to gather information about
managementpractices.Factorshypothesizedtobeassociated
with the risk of brucellosis of sheep and goats were selected
after a review of the related scientiﬁc literature [11, 22–25].
Questionnaires were administered from September, 2009 to
April, 2010. The questionnaire had 23 questions and was
grouped into four main management categories: ﬂock health
status,reproductivemanagement,nutrition,andotherfarm-
related practices. Seventeen questions were of a closed-ended
type with 2 options while 6 questions had 3 options. A
pilot testing of the questionnaire was performed on ﬁve
nonparticipating farmers to identify potential sources for
misinterpretation of the questions and to further reﬁne the
questions. Flock owners/managers were interviewed in per-
son and through the phone to complete the questionnaires.
Each personal interview lasted 20–30 min. All data from
the questionnaires were entered into SPSS database, carefully
checked and errors were corrected.
2.9. Data Analysis. Data analysis was performed using
SPSS 17.0 software for windows (SPSS Inc., Chicago, IL,
USA). Associations between the outcome variable (status
of brucellosis in the ﬂocks) and its potential risk factors
were ﬁrst screened in a univariable analysis using Chi-square
and Fisher exact tests. Potential risk factors with P value
< .25 (two tailed; α = 0.25) which provided that there
was no collinearity between variables were then considered
for further analysis. Collinearity between the potential risk
factors was assessed using χ2 test. A multivariable model for
the outcome variable was constructed using manual stepwise
forward logistic-regression analysis. Risk factors that were
not signiﬁcant in the model were re-entered whenever a
new risk factor became signiﬁcant, or a risk factor was
removed. Potential confounders were considered in every
model. A risk factor was considered as a confounder if the
point estimates of the coeﬃcients in a model changed >10%
with the potential confounder present. In the ﬁnal model,
a variable with a P value < .05 was considered statistically
signiﬁcant and retained in the model. The ﬁt of the models
was evaluated using the Hosmer and Lemeshow goodness-
of-ﬁt test [26].
3. Results
3.1. PCR Results. Of the 255 blood and tissue samples col-
lected, 107 (42%) samples were positive for Brucella; 51/106
(48.1%) and 56/149 (37.6%) fetal tissue and blood, respec-
tively.Thesepositivesamplesbelongedto86abortedanimals
(86/188 = 45.7%). To conﬁrm the presence of B. melitensis in
282-bp
M 123456789 1 0 1 1 1 2 M
(a) Agarose gel electrophoresis of PCR-ampliﬁed omp2 gene fragments
speciﬁc for Brucella spp. The ﬁgure shows a single band, a 282-bp DNA
fragment. Lanes: M: molecular 100 size ladder (in base pairs); 1–10:
Brucella positive samples for blood and fetal tissues; 11: positive control;
12: negative control.
731-bp
M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 M
(b) Agarose gel electrophoresis of PCR-ampliﬁed IS711 element speciﬁc
for B. melitensis. The ﬁgure shows a single band, a 731-bp DNA
fragment. Lanes: M: molecular 100 size ladder (in base pairs); 1–12:
B. melitensis positive samples for blood and fetal tissues; 13: positive





Figure 2: Agarose gel electrophoresis of PstI digests of ampliﬁed
omp2 gene fragments from Brucella spp. The ﬁgure shows the
uncut 282-bp DNA and the larger, PstI-digested (238-bp) DNA
fragments. The smaller 44-bp DNA fragment is not shown. Lanes:
M:molecular100sizeladder(inbasepairs);1,3,and4:B.melitensis
Rev-1 like isolates (282 and 238-bp); 2: uncut B. melitensis isolates
(282-bp); 5 and 6: B. melitensis ﬁeld strain isolates (238-bp); 7: B.
melitensis Rev-1 vaccine as a positive control.
the 107 positive samples, PCR was utilized using B. melitensis
speciﬁc primer for its IS711 element, 61 biological samples
were positive (34 tissue and 27 blood). These samples
belonged to 26 goats and 25 sheep (Figures 1(a) and 1(b)).
The puriﬁed PCR product sequencing result along with 16S
rRNA gene of B. melitensis conﬁrmed our isolates to be B.
melitensis (Figure 3). The nucleotide similarity between the
16 Brucella spp. is 100% including our B. melitensis isolate.
3.2. PCR-RFLP (PstI Enzyme). The sixty one positive sam-
ples for B. melitensis speciﬁc primers were used for RFLP
analysis to diﬀerentiate Rev-1 vaccine strain from the ﬁeld
strains infection. Thirty three (54%) of samples had vaccine
strain patterns while 2 samples (3.27%) had ﬁeld strain
pattern, but 26 samples (42, 6%) were not cut by the PstI
enzymeinRFLPanalysis(Figure 2).AnexampleoftheRev-1Veterinary Medicine International 5
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Figure 3:Nucleotidesimilarityof929nucleotidesof16srRNAgeneofBrucellaspp.1:B.abortusS19,2:B.canis,3:B.cetaceae,4:B.melitensis
biovar abortus,5 :B. melitensis biovar neotomae,6 :B. melitensis biovar abortus,7 :B. melitensis biovar canis,8 :B. melitensis biovar suis,9 :B.
melitensis biovar-1, 10: B. melitensis -Jordan, 11: B. melitensis, 12: B. melitensis biovar ovis, 13: B. microti, 14: B. ovis, 15: B. pinnipedialis, 16:
B. suis.
RFLPpatternislanes1,3,and4,theﬁeldpatternrepresented
in lane 5 and 6, and the uncut B. melitensis pattern as in
lane 2. Rev-1 vaccine DNA was extracted and was used as
a positive control in PCR-RFLP analysis.
3.3. Prevalence Rate of B. melitensis in Aborted Animals.
The crude prevalence rate of brucellosis was 27.1% (num-
ber of brucellosis positive aborted cases during the study
period/total number of aborted animals during study period
× 100) among aborted animals in Mafraq region of Jordan.
There were 32 (34.4%) ﬂocks that had at least one B.
melitensis positive samples.
3.4. Statistical Analysis. Of the 93 sampled ﬂocks that were
used in this study, we were able to ﬁll the questionnaires
for 89 farms (95.7%) during visits or through phone calls.
The other 4 ﬂocks changed their location and we were not
able to contact them for ﬁlling the questionnaires. Therefore,
data of the remaining 89 ﬂocks was used in the analysis
of this study. A total of 20 variables were screened in the
initialunivariableanalysis,3hadtheirP value< .25andwere
considered for further analysis. These three variables were
oﬀered to construct the ﬁnal logistic regression model. Two
variables remained in the ﬁnal multivariable model with a
P value < .05 (Table 1). Vaccination with Rev-1 and grazing
at common pasture were the only variables that had P value
< .05.Presenceofdogwasidentiﬁedasaconfoundervariable
and was forced in the ﬁnal model.
4. Discussion
This is the ﬁrst molecular study of ovine and caprine
brucellosis in Jordan that estimated the prevalence rate of
brucellosis in aborted animals and evaluated the risk factors
that were hypothesized to be associated with the occurrence
of this disease.
Table 1: Final logistic regression model for risk factors associated
with the B. melitensis positivity of small ruminant ﬂocks in Mafraq
region of Jordan.
Variable bS .E.b P-value OR 95% CI
for OR
Vaccination by Rev-1
in the last year
Yes 1.07 0.49 0.03 2.9 1.1, 7.8
No Ref. — — — —
Grazing at common
pasture
Yes 1.02 0.49 0.04 2.8 1.1, 7.4
No Ref. — — — —
Presence of dog in the
farm
Yes 0.31 0.48 0.51 1.4 0.53, 3.5
No Ref. — — — —
Constant 1.91 0.59 0.00
Our study revealed that the prevalence rate of brucellosis
among sheep and goat ﬂocks was in close agreement with
a previous report conducted in the region by Al-Talafhah et
al. [20] indicating that the brucellosis is an endemic health
problem of sheep and goats over the past decade in the
region. Since it has been done by many other researchers in
the same place and its rate in serology have been reported to
be between 45–56 % in sheep and goat ﬂocks using RBT and
ELISA tests [27].
G e n u ss p e c i ﬁ cp r i m e r s( omp2) showed that 41.9%
(107/255) of biological samples (blood and tissue) were
positive but 23.9% (61/255) of them were just positive for B.
melitensis speciﬁc primers (IS711). Al-Majali [27]r e p o r t e d
the presence of B. abortus biotype 9 in infected goats with6 Veterinary Medicine International
brucellosis in the same region. This might be the reason
of diﬀerent positive results in two diﬀerent primers (Genus
speciﬁc primers and IS711, speciﬁc for B. melitensis).
PCR-RFLP and multiple logistic regression results
revealed that the majority of positive cases of B. melitensis
had Rev-1 vaccine strain pattern and vaccination with Rev-1
last year was one of the main risk factors associated with the
positivity of the ﬂocks with brucellosis. This might be due to
the improper use of Rev-1 vaccine in Jordan as many farmers
continue to vaccinate their animals annually regardless of
their pregnancy status. Sheep and goats are vaccinated
annually by SC rout in Jordan with full dose vaccine of Rev-
1 live attenuated strain with no age limitations. Although
the vaccine has not to be used during pregnancy, but
some of the farmers may use it even during pregnancy
because many time the vaccine is administrated by the
farmer itself and many of them are illiterate. It has been
reported that this vaccine is not safe if it is used during
pregnancy even with reducing doses subcutaneously or
conjunctively[10,11,28–30].Recently,KojouriandGholami
[25] reported that bacteremia can be prolonged for more
than 60 days after vaccination with Rev-1 vaccine and has
the ability of dissemination from vaccinated animals to the
healthy ones. However, further ﬁeld experimental study is
essential to verify the eﬃcacy and the hazard associated
with Rev-1 vaccine in Caprine and Ovine population of
Jordan.
Our result of RFLP showed that 26 positive B. melitensis
samples were not cut by PstI enzyme. This might be due to
the ability of B. melitensis to go through genetic diversions
in the omp2 gene (a & b) [12], and this might be the reason
behind the uncut pattern.
Grazing at common pasture was also a potential risk
factor for brucellosis in sheep and goats farms. Similar
results were reported previously in the same region [27]a n d
elsewhere in the world [22, 23, 31], as it has been reported
that mixing herds at pasture and keeping the animals in
shelters during the night, represent major risk factors for
transmission of the infection [23].
Presence of dogs in the farms or with the ﬂocks was
considered a potential confounder factor that may increases
the chance of Brucella infection for the animal. In this study,
the majority of the farmers (60.7%) gave the aborted fetuses
to their dogs that were present with their ﬂocks permanently,
and possible reason is that, the dogs can be infected with
B. melitensis and Rev-1 vaccine strains and subsequently
transmittheinfectiontothefarmanimalsthroughexcretions
or mechanically [1, 23, 32].
5. Conclusions
Previous reports and our result conﬁrm that brucellosis is an
endemic disease in small ruminant ﬂocks in Mafraq/Jordan.
The number of cases of B. melitensis is relatively high among
aborted animals. It is considered as an important cause of
abortion in these species. Improper use of Rev-1 vaccine and
grazing at common pasture and presence of dogs in the ﬂock
weresigniﬁcant risk factorsassociated withthe occurrenceof
this disease in sheep and goat ﬂocks.
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